current glp-1 drugs Drugs: 6 Things We've Learned About Their Effects GLP-1 drugs can help you
Description
The question is not whether tirzepatide works long-term
The United States is the world's dominant GLP-1 receptor agonist market by an enormous margin, with over 45% of global GLP-1 revenues generated domestically despite representing less than 5% of the world's diabetes and obesity patient population
Product Overview
With diabetes and obesity cases surging in India, pharmaceutical giant Eli Lilly and Company (India) has launched Mounjaro (tirzepatide), a once-weekly injectable drug for chronic weight management and type 2 diabetes
The net effect of potential receptor activation in the context of other metabolic changes is unclear and requires further investigation
